Literature DB >> 23470270

Cardiac magnetic resonance imaging in peripartum cardiomyopathy.

Natasha Purai Arora1, Tamam Mohamad, Nitin Mahajan, Raman Danrad, Anupama Kottam, Tao Li, Luis C Afonso.   

Abstract

BACKGROUND: Peripartum cardiomyopathy (PPCM) is a rare life-threatening condition of unclear etiology. Data on the use of cardiac magnetic resonance (CMR) imaging to characterize PPCM are limited. This study was done to assess the role of CMR imaging for the diagnosis and prognostication of patients with PPCM.
METHODS: Medical records of a tertiary medical center were screened for PPCM patients with CMR imaging done within the past 5 years (2006-2011). Images were reviewed by 2 expert radiologists (blinded to clinical data) using cine sequences for chamber function and size, T2-weighted images for the determination of edema (T2-ratio), and late gadolinium enhancement (LGE) sequences for myocardial tissue characterization.
RESULTS: Ten PPCM patients (aged 28 ± 6 years, 90% African American) had a total of 15 CMR examinations: 4 in the acute phase (within 7 days of diagnosis) and 11 during follow-up (median, 12 months; range, 1-72 months). Left ventricular ejection fraction was decreased in all 4 initial scans. Elevated T2 ratio (>2) seen in 1 patient decreased on follow-up imaging. LGE was seen in 1 of the 4 acute-phase scans and in 4 of the 11 follow-up phase scans. These 4 patients had multiple readmissions because of heart failure exacerbations and persistently low left ventricular ejection fraction on subsequent echocardiograms.
CONCLUSIONS: LGE seems to be associated with a poor prognosis in the setting of PPCM. CMR imaging seems to have promising practical implications in the diagnosis and prognostication of PPCM patients.

Entities:  

Mesh:

Year:  2014        PMID: 23470270     DOI: 10.1097/MAJ.0b013e31828155e3

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  13 in total

Review 1.  Imaging of heart disease in women: review and case presentation.

Authors:  Nidaa Mikail; Alexia Rossi; Susan Bengs; Ahmed Haider; Barbara E Stähli; Angela Portmann; Alessio Imperiale; Valerie Treyer; Alexander Meisel; Aju P Pazhenkottil; Michael Messerli; Vera Regitz-Zagrosek; Philipp A Kaufmann; Ronny R Buechel; Cathérine Gebhard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-08-17       Impact factor: 10.057

Review 2.  Cardiovascular magnetic resonance in women with cardiovascular disease: position statement from the Society for Cardiovascular Magnetic Resonance (SCMR).

Authors:  Karen G Ordovas; Lauren A Baldassarre; Chiara Bucciarelli-Ducci; James Carr; Juliano Lara Fernandes; Vanessa M Ferreira; Luba Frank; Sophie Mavrogeni; Ntobeko Ntusi; Ellen Ostenfeld; Purvi Parwani; Alessia Pepe; Subha V Raman; Hajime Sakuma; Jeanette Schulz-Menger; Lilia M Sierra-Galan; Anne Marie Valente; Monvadi B Srichai
Journal:  J Cardiovasc Magn Reson       Date:  2021-05-10       Impact factor: 5.364

3.  Myocardial Damage Detected by Late Gadolinium Enhancement Cardiac Magnetic Resonance Is Uncommon in Peripartum Cardiomyopathy.

Authors:  Erik B Schelbert; Uri Elkayam; Leslie T Cooper; Michael M Givertz; Jeffrey D Alexis; Joan Briller; G Michael Felker; Sandra Chaparro; Angela Kealey; Jessica Pisarcik; James D Fett; Dennis M McNamara
Journal:  J Am Heart Assoc       Date:  2017-04-03       Impact factor: 5.501

4.  Myocardial tissue characterization and strain analysis in healthy pregnant women using cardiovascular magnetic resonance native T1 mapping and feature tracking technique.

Authors:  Masafumi Nii; Masaki Ishida; Kaoru Dohi; Hiroaki Tanaka; Eiji Kondo; Masaaki Ito; Hajime Sakuma; Tomoaki Ikeda
Journal:  J Cardiovasc Magn Reson       Date:  2018-08-02       Impact factor: 5.364

Review 5.  Peripartum Cardiomyopathy: an Update.

Authors:  Feriel Azibani; Karen Sliwa
Journal:  Curr Heart Fail Rep       Date:  2018-10

6.  The effect of bromocriptine on left ventricular functional recovery in peripartum cardiomyopathy: insights from the BRO-HF retrospective cohort study.

Authors:  Maxime Tremblay-Gravel; Guillaume Marquis-Gravel; Robert Avram; Olivier Desplantie; Anique Ducharme; Lior Bibas; Christine Pacheco; Etienne Couture; François Simard; Anthony Poulin; Isabelle Malhamé; Dan Tran; Evelyne Rey; François Tournoux; Luc Harvey; Mario Sénéchal; Pierre Bélisle; Laurence Descarries; Paul Farand; Nicolas Pranno; Ariel Diaz; Jonathan Afilalo; Hung Q Ly; Annik Fortier; Etienne Marc Jolicoeur
Journal:  ESC Heart Fail       Date:  2018-11-22

7.  The Use of a Novel Heart Failure Agent in the Treatment of Pregnancy-Associated Cardiomyopathy.

Authors:  Vamsi C Gaddipati; Aarti A Patel; Adam J Cohen
Journal:  Case Rep Cardiol       Date:  2017-08-14

8.  Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.

Authors:  Anne S Ersbøll; Annemie S Bojer; Maria G Hauge; Marianne Johansen; Peter Damm; Finn Gustafsson; Niels G Vejlstrup
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

9.  Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.

Authors:  Yao-Dan Liang; Yuan-Wei Xu; Wei-Hao Li; Ke Wan; Jia-Yu Sun; Jia-Yi Lin; Qing Zhang; Xiao-Yue Zhou; Yu-Cheng Chen
Journal:  J Cardiovasc Magn Reson       Date:  2020-01-06       Impact factor: 5.364

Review 10.  Cardiovascular disease in women: insights from magnetic resonance imaging.

Authors:  Chiara Bucciarelli-Ducci; Ellen Ostenfeld; Lauren A Baldassarre; Vanessa M Ferreira; Luba Frank; Kimberly Kallianos; Subha V Raman; Monvadi B Srichai; Elisa McAlindon; Sophie Mavrogeni; Ntobeko A B Ntusi; Jeanette Schulz-Menger; Anne Marie Valente; Karen G Ordovas
Journal:  J Cardiovasc Magn Reson       Date:  2020-09-28       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.